CSPC Pharmaceutical-UnspoadrCSPCY
13F holders, Q1 2025 (March 31)2holders
0new positions
0sold out
$2.55avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding CSPC Pharmaceutical-Unspoadr (CSPCY) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($5K) and PNC Financial Services Group, Inc. ($732).
- Company
- CSPC Pharmaceutical-Unspoadr
- Filed as
- 1SPC PHARM ADR (Q1 2025)
- CUSIP
- 12591J207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 165 shares bought and 24,073 shares sold, net −23,908 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | Reduce -92.3% | 1,995 | $5K |
| PNC Financial Services Group, Inc. | 0.00% | Add +135.3% | 287 | $732 |
"% of holder's portfolio" is CSPCY's weight in each manager's 13F, not the share of CSPC Pharmaceutical-Unspoadr the manager owns.